AI or intuition: How data saved a founder from a 60% survival rate
a founder diagnosed with rare lymphoma used anthropic's claude to aggregate 12 doctor opinions and track biomarkers, moving his survival probability from 60% to 85%.
facing a rare cancer diagnosis, founder conno christou rejected his oncologist's initial advice and used ai to crowdsource 12 specialist opinions, identifying that the recommended lighter chemo had only a 60% success rate compared to 85% for intensive treatment. he then used anthropic's claude to cross-reference bloodwork, whoop wearable data, and voice-transcribed symptom journals to manage side effects and predict immune system crashes during six months of chemotherapy. this case highlights the shift toward patients using large language models to navigate complex medical systems where specialist opinions vary wildly.